Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Physiol Res ; 67(2): 217-231, 2018 05 04.
Artículo en Inglés | MEDLINE | ID: mdl-29303603

RESUMEN

Sleep apnoea (SA) is common in patients with hypertension. Nowadays, limited data on the prevalence of SA in nocturnal hypertension (NH) exist. Therefore, we studied the occurrence of SA in Czech patients and its association with 24-h ambulatory blood pressure monitoring (ABPM), breathing disturbances in sleep, anthropometric data, Mallampati score and Epworth sleepiness scale (ESS) using the Apnea Link device. Undiagnosed SA was found in 72.9 % patients (29.3 % mild, 26.6 % moderate, 17.0 % severe) of 188 patients with NH measured by ABPM. The median of the apnoea-hypopnoea index (AHI) was 12.0 (25th-75th percentile 5.0-23.8). Moderate/severe SA (AHI>/=15) was associated with BMI, waist circumference, mean night saturation (SpO(2)), t90, oxygen desaturation index (ODI), ESS (daytime BP only) (p0.09). A likelihood of moderate/severe SA was enhanced by ODI>14.5 events/h (odds ratio=57.49, 95 % CI=22.79-145.01), t90>6.5 % (8.07, 4.09-15.92), mean night SpO(2)<93.5 % (3.55, 1.92-6.59), BMI>29.05 kg/m(2) (6.22, 3.10-12.49), circum waist>105.5 cm (3.73, 1.57-8.83), but not by any ABPM parameter. In conclusion, a high incidence of SA (72.9 %) was observed in Czech patients with NH. SA severity was associated with body characteristics and oxygenation parameters, but not with ABMP parameters and Mallampati score.


Asunto(s)
Hipertensión/epidemiología , Síndromes de la Apnea del Sueño/epidemiología , Anciano , Monitoreo Ambulatorio de la Presión Arterial , Índice de Masa Corporal , Estudios de Cohortes , República Checa/epidemiología , Femenino , Humanos , Hipertensión/complicaciones , Masculino , Persona de Mediana Edad , Oxígeno/sangre , Polisomnografía , Prevalencia , Mecánica Respiratoria , Síndromes de la Apnea del Sueño/complicaciones , Fases del Sueño , Circunferencia de la Cintura
2.
Sci Total Environ ; 407(22): 5921-5, 2009 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-19716585

RESUMEN

Investigations of environmental pollution by endocrine-disrupting chemicals are now in progress. Up to now, several in vitro bioassays have been developed for evaluation of the endocrine disruptive activity; however, there is still a lack of comparative studies of their sensitivity. In this work comparison of the estrogen screening assay based on beta-galactosidase expression and a bioluminescent estrogen screen revealed differences in the sensitivity and specificity of the two tests. With the beta-galactosidase screen a slight estrogen-like activity of Delor 103, a commercial mixture of PCB congeners, and a fungicide triclosan was measured whereas no activity was detected using the bioluminescent assay. A bioluminescent androgen test negated previously suggested androgenic potential of triclosan. Further, this work demonstrates the androgenic activity of Delor 103, with an EC(50) value of 2.29 x 10(-2)mg/L. On the other hand, chlorobenzoic acids (CBAs), representing potential PCB degradation metabolites, exhibited no androgenic activity but were slightly estrogenic. Their estrogenicity varied with their chemical structure, with 2,3-CBA, 2,3,6-CBA, 2,4,6-CBA and monochlorinated compounds exhibiting the highest activity. Thus the results indicated possible transitions of the hormonal activity of PCBs during bacterial degradation.


Asunto(s)
Andrógenos/farmacología , Bioensayo/métodos , Disruptores Endocrinos/farmacología , Estrógenos/farmacología , Bifenilos Policlorados/farmacología , Levaduras/efectos de los fármacos , Andrógenos/metabolismo , Disruptores Endocrinos/metabolismo , Contaminantes Ambientales/metabolismo , Contaminantes Ambientales/farmacología , Estrógenos/metabolismo , Bifenilos Policlorados/metabolismo , Levaduras/genética , beta-Galactosidasa/análisis , beta-Galactosidasa/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA